Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.

What symbol and exchange does Sanara Medtech shares trade?

Sanara Medtech trades on the NASDAQ stock market under the symbol SMTI.

What is Sanara Medtech stock price doing today?

As of November 2, 2026, SMTI stock price declined to $32.07 with 103,276 million shares trading.

What is Sanara Medtech's Beta?

SMTI has a beta of 1.45, meaning it tends to be more sensitive to market movements. SMTI has a correlation of 0.08 to the broad based SPY ETF.

How much is Sanara Medtech worth?

SMTI has a market cap of $294.82 million. This is considered a Small Cap stock.

How much money does Sanara Medtech make?

Last quarter Sanara Medtech reported $28 million in Revenue and -$.05 earnings per share. This fell short of revenue expectation by $-903,243 and met earnings estimates .

What is the highest and lowest price Sanara Medtech traded in the last 3 year period?

In the last 3 years, SMTI traded as high as $43.25 and as low as $16.05.

What are the top ETFs holding Sanara Medtech?

The top ETF exchange traded funds that SMTI belongs to (by Net Assets): VTI, IWM, VXF, IWO, VTWO.

Is Sanara Medtech (SMTI) a good investment?

SMTI has underperformed the market in the last year with a price return of +11.3% while the SPY ETF gained +11.7%. SMTI has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -5.8% and -3.3%, respectively, while the SPY returned +1.7% and -1.5%, respectively.

What are the support and resistance levels for Sanara Medtech (SMTI)?

SMTI support price is $32.05 and resistance is $33.61 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SMTI shares will trade within this expected range on the day.